Skip to content
London Megaproject

Providing Stem Cells in Utero to Infants with Spina Bifida Improves Quality of Life, Study Reveals

A pioneering clinical study has revealed that providing pluripotent cells to unborn babies diagnosed with spina bifida during corrective surgery can be a "major milestone" in managing prenatal disorders.

Study Parameters and Security

The American study focused on six developing infants with a severe neural tube defect. Doctors administered placenta-derived mesenchymal stem cells to the surface of the developing neural column while the defect was being closed.

Significantly, the cell therapy was found to be safe. The study team reported that the treatment did not lead to cancerous growths, interfere with wound healing, or block the correction of related neurological issues.

Encouraging Results

Imaging conducted after delivery indicated a successful correction of brainstem displacement in all six infants. This neurological improvement is strongly associated with improved motor skills and quality of life.

"Should it enable additional babies to achieve ambulation who wouldn't have, it may emerge as their standard of care," said the lead researcher. "The outcomes appear super exciting and open the door to a variety of prospective novel therapies."

Broader Impact and Encouragement

Experts not involved in the trial indicated that additional validation of these noted improvements could announce a "new era" in in-utero treatment. The potential to improve neural deficits present before birth is viewed as a paradigm-shifting aim.

Particularly welcome would be better management of continence and digestive health, which are common challenges for individuals living with this disorder.

Looking Ahead

While this initial trial was small in scale, its safety demonstration and positive signals offer a robust platform for larger, more comprehensive studies. The addition of cellular treatment with established fetal surgery techniques presents significant potential for changing life trajectories for future generations with myelomeningocele.

CR
Written by

Cindy Richards

Urban development analyst covering London's evolving architectural landscape and megaproject impacts.

London Megaproject

Type to search articles.